GlassScriptPhysician profile
Charles N Seal
NPI 1457365637
$16,831.86
in general payments reported to CMS, 2019-2025
10 companies · $4,011 in 2025
The $4,011 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $3,571 · 2021: $2,071 · 2022: $572 · 2023: $5,706 · 2024: $137 · 2025: $4,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,556 · Consulting Fee: $3,500 · Food and Beverage: $1,684 · Long Term Medical Supply Or Device Loan: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,555.74 |
| Consulting Fee | $3,500.00 |
| Food and Beverage | $1,683.61 |
| Long Term Medical Supply Or Device Loan | $114.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $8,935.18 | 2020-2025 | Excelsius Gps, Xlif |
| Alphatec Spine, INC | $5,849.25 | 2022-2023 | Other - Miscellaneous, Battalion Plif - Ps |
| Medtronic USA, INC. | $1,028.08 | 2019-2020 | |
| Medtronic, INC. | $358.05 | 2021-2022 | |
| Stryker Corporation | $310.88 | 2020-2025 | Mako, Aequalis Perform |
| Nuvasive, INC. | $161.10 | 2019-2020 | |
| Integra Lifesciences Corporation | $114.40 | 2025 | Micromatrix, Cytal |
| Centinel Spine, LLC | $38.24 | 2023 | Prodisc L |
| Kowa Pharmaceuticals America, INC. | $19.64 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Seal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.